Portefeuille van Stanley Druckenmiller
Duquesne Family Office meldde 60 aandelen ter waarde van $4,15 mld per Q3 2026. Grootste posities: NTRA 31,5%, Seagate Technology Hldngs Pl 7,60%, AMZN 4,64%.
Portefeuille$4,15 mld
Aandelen60
KwartaalQ3 2026
Top 1068,4%
Top 10 posities — 68,4% van de portefeuille
| # | Aandeel | Weging | Portefeuille | Verandering in kwartaal |
|---|---|---|---|---|
| 1 | NTNatera IncNTRA | 31,5% | $1,31 mld | −0,80% |
| 2 | SeSeagate Technology Hldngs Pl | 7,60% | $315,25 mln | +180% |
| 3 | AmazonAMZN | 4,64% | $192,49 mln | +42,6% |
| 4 | 4,60% | $190,84 mln | +38,2% | |
| 5 | YPYpf Sociedad AnonimaYPF | 4,28% | $177,56 mln | +12,8% |
| 6 | UUnity Software IncU | 3,90% | $161,94 mln | +436% |
| 7 | SESea LtdSE | 3,74% | $155,07 mln | +44,8% |
| 8 | EWIshares IncEWZ | 3,03% | $125,81 mln | −1,71% |
| 9 | 3,01% | $124,72 mln | −23,3% | |
| 10 | RVRevolution Medicines IncRVMD | 2,16% | $89,55 mln | +9,18% |
| 11 | BbBbb Foods Inc | 2,09% | $86,72 mln | −43,2% |
| 12 | STStmicroelectronics N VSTM | 2,08% | $86,20 mln | −47,9% |
| 13 | NeNewamsterdam Pharma Company | 1,97% | $81,65 mln | +9,35% |
| 14 | 1,78% | $73,79 mln | −22,6% | |
| 15 | SGSomnigroup International IncSGI | 1,49% | $61,71 mln | nieuw |
| 16 | 1,06% | $43,88 mln | nieuw | |
| 17 | BBarrick Mng CorpB | 1,03% | $42,89 mln | nieuw |
| 18 | AEAgnico Eagle Mines LtdAEM | 1,02% | $42,34 mln | nieuw |
| 19 | BiBitdeer Technologies Group | 0,96% | $39,67 mln | −7,20% |
| 20 | CPCoupang IncCPNG | 0,89% | $37,00 mln | — |
| 21 | 0,89% | $36,79 mln | nieuw | |
| 22 | PUHyperliquid Strategies IncPURR | 0,87% | $36,09 mln | — |
| 23 | 0,86% | $35,62 mln | — | |
| 24 | 0,83% | $34,62 mln | −26,4% | |
| 25 | SKChampion Homes IncSKY | 0,77% | $31,81 mln | +45,9% |
| 26 | 0,77% | $31,79 mln | nieuw | |
| 27 | CVCavco Inds Inc DelCVCO | 0,77% | $31,72 mln | +43,3% |
| 28 | DADaktronics IncDAKT | 0,75% | $31,20 mln | +59,7% |
| 29 | SPSpace Exploration Techn CorpSPCX | 0,73% | $30,49 mln | nieuw |
| 30 | RoRoku Inc | 0,68% | $28,03 mln | — |
| 31 | TTTtm Technologies IncTTMI | 0,66% | $27,21 mln | nieuw |
| 32 | RYRhythm Pharmaceuticals IncRYTM | 0,62% | $25,70 mln | +32,6% |
| 33 | 0,60% | $24,89 mln | nieuw | |
| 34 | ADAdma Biologics IncADMA | 0,53% | $22,19 mln | −20,5% |
| 35 | RIRiot Platforms IncRIOT | 0,44% | $18,25 mln | +20,0% |
| 36 | BLBelite Bio Inc SponsoredBLTE | 0,43% | $18,02 mln | — |
| 37 | BEBeam Therapeutics IncBEAM | 0,41% | $17,11 mln | +356% |
| 38 | JbJbs N.V. | 0,38% | $15,88 mln | +114% |
| 39 | RSInvesco Exchange Traded Fd TRSP | 0,37% | $15,48 mln | — |
| 40 | RLRelay Therapeutics IncRLAY | 0,37% | $15,39 mln | +144% |
| 41 | PalantirPLTR | 0,36% | $14,98 mln | nieuw |
| 42 | TSMCTSM | 0,36% | $14,92 mln | −94,5% |
| 43 | RGRepligen CorpRGEN | 0,36% | $14,88 mln | — |
| 44 | SNTd Synnex CorporationSNX | 0,35% | $14,51 mln | nieuw |
| 45 | CrCrh Plc | 0,32% | $13,20 mln | −71,2% |
| 46 | NUNuvation Bio IncNUVB | 0,31% | $12,71 mln | −50,0% |
| 47 | 0,29% | $11,92 mln | −74,3% | |
| 48 | PCPurecycle Technologies IncPCT | 0,29% | $11,82 mln | — |
| 49 | NSInsight Enterprises IncNSIT | 0,25% | $10,49 mln | nieuw |
| 50 | SKSkeena Res Ltd NewSKE | 0,21% | $8,93 mln | — |
| 51 | KRKorsana Biosciences IncKRSA | 0,21% | $8,91 mln | nieuw |
| 52 | OLOlema Pharmaceuticals IncOLMA | 0,21% | $8,53 mln | — |
| 53 | 0,20% | $8,47 mln | nieuw | |
| 54 | RKRocket Cos IncRKT | 0,18% | $7,51 mln | — |
| 55 | COCogent Biosciences IncCOGT | 0,17% | $7,08 mln | nieuw |
| 56 | MLMoonlake ImmunotherapeuticsMLTX | 0,14% | $5,78 mln | nieuw |
| 57 | 0,11% | $4,40 mln | −69,3% | |
| 58 | AUAurora Innovation IncAUR | 0,08% | $3,51 mln | — |
| 59 | DBDbv Technologies S ADBVT | 0,05% | $2,04 mln | −54,9% |
| 60 | WVWave Life Sciences IncWVE | 0,01% | $640.000 | nieuw |
Volledig verkocht
| $120,18 mln | |
| $108,08 mln | |
| $79,35 mln | |
| $56,48 mln | |
| $48,70 mln | |
| AMDAMD | $42,35 mln |
| $39,59 mln | |
| HUHut 8 CorpHUT | $36,27 mln |
| CACaris Life Sciences IncCAI | $33,76 mln |
| ARGlobal X FdsARGT | $30,02 mln |
| WWWoodward IncWWD | $28,59 mln |
| PTProtagonist Therapeutics IncPTGX | $25,61 mln |
| RMRambus Inc DelRMBS | $22,96 mln |
| SCSouthern Copper CorpSCCO | $21,44 mln |
| LiLinde Plc | $21,38 mln |
Een 13F toont alleen in de VS genoteerde aandelen en ETF’s, alleen long-posities en tot 45 dagen na het kwartaal. Geen beleggingsadvies. Bron: SEC EDGAR, 13F-HR van 2026-11-16. SEC ↗